Preferred Label : agonists;

Details


Main resources

You can consult :


http://lemedecinduquebec.org/archives/2016/12/exenatide-et-dulaglutide-traiter-le-diabete-une-fois-par-semaine/
2016
false
false
false
Canada
French
journal article
Glucagon-Like Peptide-1 Receptor
incretins
hypoglycemic agents
diabetes mellitus, type 2
drug therapy, combination
injections, subcutaneous
exenatide
dulaglutide
Once Weekly
drug interactions
treatment outcome
weight loss
recombinant fusion proteins
glucagon-like peptides
quebec
dulaglutide
exenatide
immunoglobulin fc fragments
peptides
venoms

---
http://www.revmed.ch/rms/2014/RMS-N-439/Interet-d-une-combinaison-agoniste-des-recepteurs-du-GLP-1-et-insuline-basale-dans-le-traitement-du-diabete-de-type-2
2014
false
false
false
Switzerland
French
journal article
drug therapy, combination
hypoglycemic agents
diabetes mellitus, type 2
insulin
treatment outcome
Incretin mimetic agent (substance)
incretins
drug combinations
blood glucose
exenatide
gastric emptying
injections, subcutaneous
Delayed-Action preparations
hyperglycemia, postprandial
semaglutide
rGLP-1 protein
body weight
Liraglutide
Glucagon-Like Peptide-1 Receptor
lixisenatide
hyperglycemia
dulaglutide
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
glucagon-like peptides
peptides
venoms
glucagon-like peptide 1
glucagon-like peptide 1

---
http://www.amub.be/revue-medicale-bruxelles/article/les-nouveaux-anti-diabetiques-oraux-1032
http://www.amub.be/revue-medicale-bruxelles/download/1032
2014
false
false
false
false
Belgium
French
journal article
comparative study
diabetes mellitus, type 2
incretins
hypoglycemic agents
administration, oral
incretins
gastric inhibitory polypeptide
glucagon-like peptide 1
dipeptidyl-peptidase iv inhibitors
dipeptidyl peptidase (dpp-4) inhibitors
other blood glucose lowering drugs, excl. insulins
incretins
hypoglycemic agents
hypoglycemic agents
SLC5A2 protein, human
risk factors
drug therapy, combination
treatment outcome
Glucagon-Like Peptide-1 Receptor
Sodium-Glucose transporter 2

---
http://www.has-sante.fr/portail/jcms/c_1774157/fr/salvacyl
2014
true
France
French
evaluation of the transparency committee
treatment outcome
Delayed-Action preparations
triptorelin pamoate
insurance, health, reimbursement
gonadotropin-releasing hormone
Paraphilic Disorders
injections, intramuscular
adult
testosterone
triptorelin

---
http://www.cochrane.org/fr/CD010693/medicaments-pour-la-prevention-de-la-recurrence-de-lavc-et-autres-evenements-vasculaires-chez-les-patients-ayant-deja-eu-un-avc-ou-un-accident-ischemique-transitoire
false
false
false
France
meta-analysis
french abstract
stroke
secondary prevention
ischemic attack, transient
peroxisome proliferator-activated receptors
treatment outcome

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Diabete-de-type-2-nouvelles-donnees-sur-le-risque-pancreatique-chez-les-patients-diabetiques-traites-par-les-incretinomimetiques-Point-d-information/(language)/fre-FR
2013
false
France
French
Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
Sitagliptin Phosphate
Linagliptin
Liraglutide
Glucagon-Like Peptide-1 Receptor
exenatide
liraglutide
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
hypoglycemic agents
pharmacovigilance note
Incretin mimetic agent (substance)
Incretin mimetic product (product)
pancreatic diseases
risk
exenatide
lixisenatide
sitagliptin
metformin and sitagliptin
saxagliptin
metformin and saxagliptin
saxagliptin
drug combinations
linagliptin
metformin and linagliptin
vildagliptin
metformin and vildagliptin
vildagliptin
peptides
venoms
nitriles
pyrrolidines
adamantane
dipeptides

---
http://www.cochrane.org/fr/CD002808
2013
France
French
french abstract
meta-analysis
gonadotropin-releasing hormone
time
fertilization in vitro
treatment outcome
pituitary gland

---
http://www.cochrane.org/fr/CD006318
2011
false
true
false
France
pregnancy
narcotics
treatment outcome
review of literature
french abstract
opioid-related disorders
pregnant women

---
https://medicalforum.ch/fr/article/doi/fms.2011.07600/
2011
false
true
false
Switzerland
thrombocytopenia
journal article
receptors, thrombopoietin

---
http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/13541a-fra.php
2011
Canada
French
English
pharmacovigilance note
Cardiotoxicity
risk
gonadotropin-releasing hormone
gonadotropin-releasing hormone
prostatic neoplasms
stroke
myocardial infarction

---
http://www.cochrane.org/fr/CD008235
2011
false
true
false
France
receptors, thrombopoietin
receptors, thrombopoietin
treatment outcome
review of literature
french abstract
purpura, thrombocytopenic, idiopathic

---
http://www.cochrane.org/fr/CD008046
2011
false
true
false
France
chorionic gonadotropin
gonadotropin-releasing hormone
oogenesis
treatment outcome
review of literature
french abstract
gonadotropin-releasing hormone

---
http://www.has-sante.fr/portail/jcms/c_812373/salvacyl-lp-triptoreline-agoniste-de-la-lhrh
2009
false
France
French
guidelines for drug use
evaluation of the transparency committee
treatment outcome
Delayed-Action preparations
triptorelin pamoate
insurance, health, reimbursement
gonadotropin-releasing hormone
Paraphilic Disorders
injections, intramuscular
adult
testosterone
triptorelin

---
https://www.revmed.ch/RMS/2009/RMS-206/Role-et-place-des-analogues-du-GLP-1-dans-le-traitement-du-diabete-de-type-2
2009
false
Switzerland
French
Liraglutide
Glucagon-Like Peptide-1 Receptor
exenatide
liraglutide
diabetes mellitus, type 2
glucagon-like peptide 1
Incretin mimetic product (product)
Incretin mimetic agent (substance)
exenatide
hypoglycemic agents
peptides
venoms
journal article
incretins

---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/met/e-docs/00/04/41/01/resume.md?type=text.html
2008
France
French
receptors, thrombopoietin
receptors, thrombopoietin
purpura, thrombocytopenic, idiopathic
journal article

---
E-mail
16/12/2017


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.